Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
McKesson
Moodys
Express Scripts
Merck

Last Updated: December 11, 2019

DrugPatentWatch Database Preview

Porfimer sodium - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic sources for porfimer sodium and what is the scope of patent protection?

Porfimer sodium is the generic ingredient in one branded drug marketed by Concordia Labs Inc and is included in one NDA. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for porfimer sodium
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Bulk Api Vendors: 7
Clinical Trials: 28
Patent Applications: 6,679
DailyMed Link:porfimer sodium at DailyMed
Recent Clinical Trials for porfimer sodium

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Cancer Institute (NCI)Phase 1
Roswell Park Cancer InstitutePhase 1
Concordia Laboratories Inc.Phase 1

See all porfimer sodium clinical trials

Pharmacology for porfimer sodium
Drug ClassPhotoactivated Radical Generator
Mechanism of ActionPhotoabsorption
Physiological EffectPhotosensitizing Activity

US Patents and Regulatory Information for porfimer sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Concordia Labs Inc PHOTOFRIN porfimer sodium INJECTABLE;INJECTION 020451-001 Dec 27, 1995 RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for porfimer sodium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Concordia Labs Inc PHOTOFRIN porfimer sodium INJECTABLE;INJECTION 020451-001 Dec 27, 1995   Start Trial   Start Trial
Concordia Labs Inc PHOTOFRIN porfimer sodium INJECTABLE;INJECTION 020451-001 Dec 27, 1995   Start Trial   Start Trial
Concordia Labs Inc PHOTOFRIN porfimer sodium INJECTABLE;INJECTION 020451-001 Dec 27, 1995   Start Trial   Start Trial
Concordia Labs Inc PHOTOFRIN porfimer sodium INJECTABLE;INJECTION 020451-001 Dec 27, 1995   Start Trial   Start Trial
Concordia Labs Inc PHOTOFRIN porfimer sodium INJECTABLE;INJECTION 020451-001 Dec 27, 1995   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Harvard Business School
Dow
McKinsey
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.